Plan Frente A La Pandemia Por COVID-19 Para El Año 2022

Pandemic Preparedness and Response Health Action Plan 2022
Peru Spanish PDF
National

AI-Generated Document Summary

Objectives

Peru’s 2022 Technical Plan for COVID-19 Preparedness and Response seeks to protect the lives and health of people at risk of, or affected by, COVID-19, reducing morbidity, mortality, disability, harm and complications nationwide through territorial management.It addresses the central problem of heightened exposure risk and the pandemic’s substantial effects on the population, within a context of a projected third wave and high prior mortality, particularly among older adults.

  • Improve the Ministry of Health’s capacity to prevent and reduce COVID-19 morbidity, mortality and disability throughout the country.
  • Prevent and control community transmission through an integrated life-course health-care model.
  • Strengthen health-service capacity to maintain care for people with COVID-19 and for those with other health conditions.
  • Reinforce multisectoral, intergovernmental, territorial and social participation in the pandemic response.
  • Prioritise vaccination, early case detection, epidemiological surveillance, contact tracing, clinical follow-up, service continuity, health-system capacity and social responsibility.
  • Align action with the Ministry of Health Strategic Institutional Plan 2019-2024, including disease prevention and control, quality access through integrated health networks, and stronger stewardship and governance.

The target population is Peru’s estimated 2022 population of 33,396,698 people, including approximately 1,301,315 Venezuelan immigrants; health surveillance estimated 2,276,981 people as susceptible to COVID-19 infection.The plan incorporates human rights, gender equity, intercultural health and territorial-management approaches, including culturally appropriate vaccination communication for Andean and Amazonian Indigenous peoples and the Afro-Peruvian population.

Priority service objectives include strengthening first-, second- and third-level care; managing mild cases through Temporary Isolation and Case-Follow-up Centres and Temporary Oxygen Therapy Centres; expanding temporary hospitalisation and critical-care capacity; and improving medicinal-oxygen coverage across all care levels.The plan also seeks to strengthen laboratory capacity for timely molecular diagnosis, workplace risk prevention and surveillance, identification of post-COVID-19 sequelae, and public communication on vaccination, prevention and control.

Implementation

Implementation combines central Ministry of Health leadership with regional and local coordination, integrated service delivery, surveillance-led targeting and operational monitoring. The plan is mandatory for participating Ministry of Health and National Institute of Health bodies and organisational units, and is a reference for regional authorities and public, private and mixed health institutions preparing 2022 COVID-19 plans.It was formulated jointly by the Vice-Ministerial Offices for Public Health and for Health Services and Insurance, with Ministry of Health and National Institute of Health participation.

  • Deliver first-level COVID-19 care through fixed, mobile and telehealth modalities, supported by multidisciplinary Integral Intervention Teams trained in surveillance, specimen collection, syndromic management, clinical follow-up and individual and public-health interventions.
  • Organise referral, counter-referral, bed management, hospital and intensive-care access, temporary isolation, oxygen therapy, medical supplies, personal protective equipment, medicines and medical devices across care levels.
  • Operate Temporary Care and Isolation Centres affiliated with second- or third-level facilities, under a medical director or designated health-care lead, using adapted premises such as hospital-adjacent areas, stadiums, fairgrounds and educational institutions.
  • Expand medicinal-oxygen infrastructure, cylinders and concentrators, alongside monitoring of oxygen producers, distributors, stocks and consumption through the RENOXI-Peru application.
  • Implement vaccination through the updated national vaccination plan, cold-chain strengthening, technical assistance, information systems and targeted communication.
  • Detect suspected cases early through molecular and antigen testing, trace and monitor contacts, follow confirmed cases, identify transmission hotspots and monitor emerging SARS-CoV-2 variants.
  • Conduct workplace surveillance and inspection of COVID-19 prevention and control plans, risk-and-harm surveillance, post-COVID medical and psychological assessments, and outbreak surveillance in workplaces, markets, transport and other settings.

Governance includes coordination among the Ministry of Health, regional and local governments, regional health authorities, health facilities, laboratories, Integrated Health Networks, public insurance institutions and relevant technical bodies.The Ministry of Health Regional Liaison Sectoral Team supports linkage, coordination and monitoring between the Ministry and regional authorities.Regional Health Directorates and Regional Health Management Offices are responsible for formulating, approving, implementing, monitoring and evaluating regional plans aligned with the national plan.

The General Directorate for Disaster Risk Management and National Health Defence is responsible for supervising, monitoring and evaluating the plan, obtaining activity and target-compliance reports from Ministry of Health and National Institute of Health units, and consolidating these into technical reports.The General Office for Decentralised Management, through Regional Liaison Sector Teams, supports monitoring of regional implementation.Annexes provide an indicator matrix and matrices for programming and tracking physical and budgetary targets.

Operational information systems support surveillance, notification and capacity management, including NotiCovid, SISCOVID, NetLab, SICOVID-19 for centralised hospital-bed availability, vaccination-monitoring systems, telemonitoring and contact-alert tools.Monitoring covers case trends, hospital and intensive-care demand, bed availability, oxygen stocks, laboratory capacity, vaccination, health-worker resources, health-care-associated infections and public-health threats under the International Health Regulations.

The 2022 budget totals 6,647,320,781 Peruvian soles, comprising 6,447,298,560 Peruvian soles for the Ministry of Health and 200,022,220 Peruvian soles for the National Institute of Health.Activities are financed from resources referenced in Article 53 of Legislative Decree No. 1440; the extracts do not identify funding gaps or additional resource-mobilisation measures.

Monitoring & Evaluation

The plan combines epidemiological surveillance, operational service monitoring and structured implementation oversight, although the supplied material does not provide a single consolidated set of outcome targets, indicator definitions or reporting calendar.

  • Monitor COVID-19 transmission through early identification of suspected cases, molecular and antigen testing, contact tracing, clinical follow-up and surveillance of emerging SARS-CoV-2 variants.
  • Use national notification systems to report diseases, outbreaks, epidemics and other public-health events, supported by case data from NotiCovid, SISCOVID and NetLab.
  • Track confirmed cases, attack rates, deaths and case-fatality rates by age, sex and region, alongside weekly national and regional case trends.
  • Monitor health-system pressure through hospitalisation, intensive-care use, bed occupancy, bed availability and effective reproduction numbers.
  • Manage hospital-bed availability centrally through the SICOVID-19 application and F500.2 format, covering hospitalisation and intensive-care capacity.
  • Track temporary-care infrastructure and utilisation, including CATS, COTs and Temporary Care and Isolation Centres, through SICOVID-19, the Ministry of Health Cloud and the Directorate for Monitoring and Evaluation of Health Management.
  • Monitor oxygen infrastructure, cylinder availability and health-workforce data through the Directorate-General for Health Operations, the National Register of Medicinal Oxygen and INFORHUS.
  • Track vaccination coverage, including first, second and third doses and vaccination of children aged 5 to 11 years, through Ministry of Health information systems.
  • Use operational indicators covering vaccination, suspected and confirmed cases, notification, diagnostic testing, contact follow-up and public-information campaigns.
  • Strengthen sentinel surveillance for COVID-19, influenza and other respiratory viruses; identify transmission hotspots; detect outbreaks and public-health threats promptly; and monitor vaccine safety, including serious events allegedly attributable to vaccination or immunisation.
  • Supervise healthcare-associated infection outbreaks, priority intensive-care units, essential-goods availability, oxygen stocks and consumption, including reporting through the RENOXI-Peru application.
  • Conduct workplace risk and harm surveillance, inspect workplace prevention and control plans, identify post-COVID-19 sequelae among workers, and investigate outbreaks in workplaces, markets, transport and other settings.
  • Undertake sanitary surveillance of COVID-19 healthcare waste, monitor deceased-person management, and strengthen surveillance at specified air and land points of entry under the International Health Regulations.
  • Assign the General Directorate for Disaster Risk Management and National Health Defence to supervise, monitor and evaluate the plan, request activity and target-compliance reports, and consolidate these into technical reports for relevant bodies.
  • Require regional health authorities to formulate, implement, monitor and evaluate aligned regional plans, with support from the General Office for Decentralised Management through Regional Liaison Sector Teams.
  • Use annexed indicator matrices and matrices for programming and tracking 2022 physical and budgetary targets.

Formal evaluation methods, indicator baselines and targets, reporting frequency, public disclosure arrangements and independent accountability mechanisms are not specified in the supplied extracts.

Costing & Financing

The 2022 COVID-19 plan has an explicit total budget of 6,647,320,781 Peruvian soles, with funding assigned to the Ministry of Health and the National Institute of Health; most other extracts describe budget-linked activities or resource requirements without monetary detail.

  • Allocate 6,447,298,560 Peruvian soles to budget holder 011, the Ministry of Health, and 200,022,220 Peruvian soles to budget holder 131, the National Institute of Health.
  • Finance plan activities from resources referred to in Article 53 of Legislative Decree No. 1440 on the National Public Budget System.
  • Estimate the final 2022 budget using rounded amounts under the cited budget-execution directive.
  • Align Ministry of Health and National Institute of Health operational activities with their respective 2022 Opening Institutional Budgets and institutional operating plans.
  • Programme and track physical and budgetary targets through dedicated formulation and monitoring matrices.
  • Support procurement and distribution of strategic COVID-19 prevention and treatment resources through Ministry of Health financing, including referenced acquisitions, contracts, ambulance operations and IOARR 2520241.

The extracts identify a risk of inadequate budget programming for continuous medicinal-oxygen supply, but do not quantify this risk or identify a funding gap.They do not specify detailed allocations for laboratory capacity, vaccination, workforce, temporary facilities, telehealth, oxygen, communications or surveillance, nor additional resource-mobilisation measures or wider economic assumptions.

Two entries of 1,000 appear in a 2022 budget matrix, including one associated with a DIOTEL row, but the source does not identify their unit, budget category, currency or meaning.

Document Viewer